TCT 728: Impact of Neutrophil-to-Lymphocyte Ratio on Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention  

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Consultant Fee/Honoraria/Speaker's Bureau - Terumo Medical Corporation